New Research Identifies Biomarkers that Could Improve Dementia Risk Prediction

In a study of cognitively healthy adults, elevated levels of two biomarkers measured in the blood, GDF15 and NT-proBNP, were associated with an increased risk of developing dementia in later life

New research from Boston University, Harvard Medical School and NUI Galway’s HRB-Clinical Research Facility has identified two blood biomarkers that could help identify those at risk of developing dementia later in life. The study was published today in the Journal of the American Heart Association.